Status:
COMPLETED
Sedative-Anxiolytic Effects on Simulated Driving Performance
Lead Sponsor:
Marion Coe
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Psychomotor Impairment
Eligibility:
All Genders
18-50 years
Phase:
PHASE4
Brief Summary
This study evaluates the effect of anxiety drugs taken at night on the ability to drive a car the next day. Participants will receive alprazolam, placebo, or zolpidem at night before bed or in the mor...
Eligibility Criteria
Inclusion
- valid driver's license
- english-speaking and literate
Exclusion
- using daily medication for chronic condition
- acute narrow angle glaucoma
- previous adverse experience with study drugs
- experiences motion sickness in response to driving simulator
- BMI \> 30
- women who are pregnant, lactating, or planning on becoming pregnant
- regular use of tobacco products
- current substance use disorder
- clinically significant ECG
- current ongoing psychiatric disorder
Key Trial Info
Start Date :
September 15 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 25 2018
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT03297944
Start Date
September 15 2017
End Date
October 25 2018
Last Update
January 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center on Drug and Alcohol Research
Lexington, Kentucky, United States, 40508